EWM
IART icon

Executive Wealth Management’s Integra LifeSciences IART Stock Holding History

Executive Wealth Management’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-852
Closed -$48K – 423
2019
Q2 		$48K Hold
852
– – 0.01% 299
2019
Q1 		$47K Hold
852
– – 0.01% 279
2018
Q4 		$38K Buy
+852
New +$46.7K 0.01% 321

Other funds holding IART

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Executive Wealth Management's IART Position: Q3 2019 in Review

Executive Wealth Management sold out of Integra LifeSciences (IART) in Q3 2019, closing a stake of 852 shares — an estimated $48K sold.

Executive Wealth Management first reported a position in IART in Q4 2018 and held it in 3 quarters. The position peaked at $48K in Q2 2019. 280 funds tracked by Wall St. Rank hold IART as of Q3 2019.

  • Executive Wealth Management reported no remaining Integra LifeSciences position as of Q3 2019 after selling out during the quarter.
  • Executive Wealth Management sold 852 Integra LifeSciences shares in Q3 2019, an estimated $48K.
  • Executive Wealth Management first reported a position in Integra LifeSciences in Q4 2018 and held it in 3 quarters.
  • Executive Wealth Management's Integra LifeSciences position peaked at $48K in Q2 2019.
  • 280 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2019.

Based on Executive Wealth Management's 13F filing for Q3 2019, filed 30 Oct 2019.